Search results for: “biopharmaceutical”
-
Ipsen appoints Gwenan White as EVP Communications and Public Affairs
•
PARIS: Ipsen announced today the appointment of Gwenan White as Executive Vice President, Communications and Public Affairs, effective…
-
Oncolytics Biotech Inc.
•
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic…
-
Sanofi to acquire Kymab for an upfront payment of approximately $1.1 billion
•
PARIS: Sanofi and Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies with a focus on immune-mediated…
-
AstraZeneca completes Atacand divestment to Cheplapharm in more than 70 countries
•
LONDON, UK: AstraZeneca has completed the divestment of commercial rights to Atacand (candesartan cilexetil) and Atacand Plus (a…
-
IXICO secures new contract for £3.4 million
•
LONDON: IXICO plc, the AI data analytics company delivering insights in neuroscience, has been awarded a £3.4 million…
-
Jeffrey A. Bluestone joins Gilead Sciences’ Board of Directors
•
FOSTER CITY: Gilead Sciences Inc. announced today that Jeffrey A. Bluestone, PhD, has been appointed to the company’s…
-
Forma Therapeutics launches proposed public offering of 4.6m shares
•
WATERTOWN: Forma Therapeutics Holdings it has launched a proposed public offering of 4.6 million shares of its common…
-
Sinovac secures $500 million Funding for COVID-19 vaccine development
•
BEIJING: Sinovac Life Sciences Co., Ltd. has secured approximately US$500 million in funding for further development, capacity expansion…
-
Takashi Nagao appointed President and CEO of Medicago
•
QUEBEC CITY: Medicago, a biopharmaceutical company headquartered in Quebec City, Canada, announced Takashi Nagao as the company’s new…
-
AstraZeneca sells Crestor to Grünenthal in Europe in a $320 million deal
•
LONDON: AstraZeneca has agreed to sell the rights to Crestor (rosuvastatin) and associated medicines in over 30 countries…
-
Uniphar plc announces acquisition of RRD International
•
DUBLIN: Uniphar plc has announced the acquisition of US-based, RRD International. RRD is a US based pharmaceutical advisory…
-
Verona Pharma signs $30 million debt financing with Silicon Valley Bank
•
LONDON: Verona Pharma plc has entered into a debt financing facility for up to $30 million with Silicon…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.